Development of a highly specific serodiagnostic ELISA for West Nile virus infection using subviral particles

[1]  G. Screaton,et al.  High flavivirus structural plasticity demonstrated by a non-spherical morphological variant , 2020, Nature Communications.

[2]  H. Sawa,et al.  Amino acid 159 of the envelope protein affects viral replication and T-cell infiltration by West Nile virus in intracranial infection , 2020, Scientific Reports.

[3]  Y. Orba,et al.  West Nile virus capsid protein inhibits autophagy by AMP-activated protein kinase degradation in neurological disease development , 2020, PLoS pathogens.

[4]  J. Cardoso,et al.  First isolation of West Nile virus in Brazil , 2019, Memorias do Instituto Oswaldo Cruz.

[5]  Y. Orba,et al.  Development of a rapid and quantitative method for the analysis of viral entry and release using a NanoLuc luciferase complementation assay. , 2018, Virus research.

[6]  B. Durand,et al.  Improved reliability of serological tools for the diagnosis of West Nile fever in horses within Europe , 2017, PLoS neglected tropical diseases.

[7]  Y. Qiu,et al.  Immunization with truncated envelope protein of Zika virus induces protective immune response in mice , 2017, Scientific Reports.

[8]  Andrew S. Miller,et al.  A human antibody against Zika virus crosslinks the E protein to prevent infection , 2017, Nature Communications.

[9]  K. Yoshii,et al.  Development of a serodiagnostic multi-species ELISA against tick-borne encephalitis virus using subviral particles. , 2016, Ticks and tick-borne diseases.

[10]  A. Harada,et al.  Rab8b Regulates Transport of West Nile Virus Particles from Recycling Endosomes* , 2016, The Journal of Biological Chemistry.

[11]  Andriyan Grinev,et al.  The Global Ecology and Epidemiology of West Nile Virus , 2015, BioMed research international.

[12]  V. Kostyuchenko,et al.  A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins , 2015, Nature Communications.

[13]  V. Nerurkar,et al.  Characterization of the Ectodomain of the Envelope Protein of Dengue Virus Type 4: Expression, Membrane Association, Secretion and Particle Formation in the Absence of Precursor Membrane Protein , 2014, PloS one.

[14]  M. Brinton.  Replication Cycle and Molecular Biology of the West Nile Virus , 2013, Viruses.

[15]  O. Vapalahti,et al.  Diagnostic Potential and Antigenic Properties of Recombinant Tick-Borne Encephalitis Virus Subviral Particles Expressed in Mammalian Cells from Semliki Forest Virus Replicons , 2013, Journal of Clinical Microbiology.

[16]  K. Stiasny,et al.  The Membrane-Proximal “Stem” Region Increases the Stability of the Flavivirus E Protein Postfusion Trimer and Modulates Its Structure , 2013, Journal of Virology.

[17]  E. Fikrig,et al.  West Nile Virus: Biology, Transmission, and Human Infection , 2012, Clinical Microbiology Reviews.

[18]  Y. Orba,et al.  Accumulation of ubiquitinated proteins is related to West Nile virus‐induced neuronal apoptosis , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[19]  Kensuke Nakajima,et al.  Seroprevalence of West Nile virus in wild birds in far eastern Russia using a focus reduction neutralization test. , 2011, The American journal of tropical medicine and hygiene.

[20]  K. Stiasny,et al.  The Unique Transmembrane Hairpin of Flavivirus Fusion Protein E Is Essential for Membrane Fusion , 2011, Journal of Virology.

[21]  A. Amarilla,et al.  Domain III peptides from flavivirus envelope protein are useful antigens for serologic diagnosis and targets for immunization. , 2010, Biologicals : journal of the International Association of Biological Standardization.

[22]  M. Diamond,et al.  Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354 , 2010, Proceedings of the National Academy of Sciences.

[23]  H. Matsuda,et al.  Cross-reactivity of Japanese encephalitis virus-vaccinated horse sera in serodiagnosis of West Nile virus. , 2010, The Journal of veterinary medical science.

[24]  T. Oliphant,et al.  Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein , 2006, Journal of Virology.

[25]  K. Stiasny,et al.  Cryptic Properties of a Cluster of Dominant Flavivirus Cross-Reactive Antigenic Sites , 2006, Journal of Virology.

[26]  R. Doms,et al.  N-Linked Glycosylation of West Nile Virus Envelope Proteins Influences Particle Assembly and Infectivity , 2005, Journal of Virology.

[27]  K. Shirato,et al.  Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus. , 2004, The Journal of general virology.

[28]  J. Dubuisson,et al.  The Transmembrane Domains of the prM and E Proteins of Yellow Fever Virus Are Endoplasmic Reticulum Localization Signals , 2004, Journal of Virology.

[29]  A. Barrett,et al.  Use of Recombinant E Protein Domain III-Based Enzyme-Linked Immunosorbent Assays for Differentiation of Tick-Borne Encephalitis Serocomplex Flaviviruses from Mosquito-Borne Flaviviruses , 2004, Journal of Clinical Microbiology.

[30]  S. Harrison,et al.  Two Distinct Size Classes of Immature and Mature Subviral Particles from Tick-Borne Encephalitis Virus , 2003, Journal of Virology.

[31]  J. H. Strauss,et al.  Visualization of membrane protein domains by cryo-electron microscopy of dengue virus , 2003, Nature Structural Biology.

[32]  J. Dubuisson,et al.  Role of the Transmembrane Domains of prM and E Proteins in the Formation of Yellow Fever Virus Envelope , 2003, Journal of Virology.

[33]  A. Osterhaus,et al.  Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. , 2002, Microbes and infection.

[34]  F. Heinz,et al.  Structures and mechanisms in flavivirus fusion , 2000, Advances in Virus Research.

[35]  J. Butler.  Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. , 2000, Methods.

[36]  Denise A. Martin,et al.  Standardization of Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assays for Routine Diagnosis of Arboviral Infections , 2000, Journal of Clinical Microbiology.

[37]  C. Mandl,et al.  Mapping of Functional Elements in the Stem-Anchor Region of Tick-Borne Encephalitis Virus Envelope Protein E , 1999, Journal of Virology.

[38]  C. Mandl,et al.  Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions , 1996, Journal of virology.

[39]  C. Mandl,et al.  Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form , 1995, Journal of virology.

[40]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[41]  E. Paoletti,et al.  Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. , 1992, Virology.

[42]  E. Protopopova,et al.  [The genotyping of the West Nile virus in birds in the far eastern region of Russia in 2002-2004]. , 2006, Molekuliarnaia genetika, mikrobiologiia i virusologiia.

[43]  J. Butler.  Solid supports in enzyme-linked immunosorbent assay and other solid-phase immunoassays. , 2004, Methods in molecular medicine.

[44]  N. Komar.  West Nile virus: epidemiology and ecology in North America. , 2003, Advances in virus research.

[45]  J. Meece,et al.  Birds, migration and emerging zoonoses: west nile virus, lyme disease, influenza A and enteropathogens. , 2003, Clinical medicine & research.

[46]  G. Kuno.  Serodiagnosis of flaviviral infections and vaccinations in humans. , 2003, Advances in virus research.

[47]  O. V. Platonova,et al.  Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. , 2001, Emerging infectious diseases.

[48]  C. Mandl,et al.  Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. , 1995, Vaccine.

[49]  E. Paoletti,et al.  Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice. , 1994, Vaccine.

[50]  A. Igarashi.  Epidemiology and control of Japanese encephalitis. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[51]  E. Paoletti,et al.  Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection. , 1991, Virology.

[52]  N. Karabatsos,et al.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. , 1989, The Journal of general virology.